top of page
(OTC: KRTL)
Home
About
Team
News
Contact
More
Use tab to navigate through the menu items.
KRTL News
All Posts
Log in / Sign up
Mar 3
KRTL Biotech Implements MasterControl QMS to Enhance Regulatory Compliance and Pharmaceutical Importation Readiness
Feb 12
KRTL Holding Group Inc. Welcomes Dr. Marcelo Bascope as Chief International Science Director
Feb 12
KRTL Holding Group Inc. Appoints Marlen Patricia Wilstermann-Sanzetenea as International Pharmaceutical Sales Director
Feb 12
KRTL Holding Group Inc. Appoints Philip Polito to Board of Directors as Chief Strategy Officer
Feb 5
KRTL Holding Group Expands in Bolivia: A Strategic Leap for Biopharmaceutical Innovation
Jan 22
KRTL Holding Group Inc. Announces Milestone Achievement: FDA Registration of Industria QuÃmico Farmaceutica SIGMA CORP. S.R.L.’s Federal Establishment Identifier
Jan 15
KRTL Holding Group Inc. Announces FDA FEI and NDC Certification Achievements by Wholly Owned Subsidiary KRTL Biotech Inc.
Jan 8
KRTL Holding Group Inc. Announces KRTL Biotech Inc. Acquires 55% Majority Stake in Nutrivance Global to Enhance API Distribution and Real-World Data Capabilities
Jan 8
KRTL Holding Group Inc. (OTC: KRTL) Announces Launch of New KRTL Biotech Website to Streamline Pharmaceutical Industry Solutions
Dec 19, 2024
KRTL Holding Appoints David Orn to Board of Directors
Dec 5, 2024
KRTL Holding Announces KRTL Biotech Facilitates FDA Registration of SIGMACORP as a U.S. Pharmaceutical Manufacturer
Nov 26, 2024
A Milestone for KRTL Holding Group, Inc. (OTC: KRTL)
bottom of page
